浙江预防医学
浙江預防醫學
절강예방의학
ZHEJIANG JOURNAL OF PREVENTIVE MEDICINE
2015年
5期
466-468,476
,共4页
周绍英%边国林%马瑞%倪红霞%方挺%陈小英%董红军
週紹英%邊國林%馬瑞%倪紅霞%方挺%陳小英%董紅軍
주소영%변국림%마서%예홍하%방정%진소영%동홍군
新生儿%乙型肝炎疫苗%免疫应答
新生兒%乙型肝炎疫苗%免疫應答
신생인%을형간염역묘%면역응답
Infants%Hepatitis B vaccine%Immunologic response
目的:了解新生儿接种不同类型乙型肝炎(乙肝)疫苗(HepB)后不同时期的免疫应答状况。方法选择余姚市和宁海县乙肝病毒表面抗原(HBsAg)阴性母亲2375人在2009年7月1日—12月31日分娩的新生儿作为研究对象,按照0、1、6个月免疫程序分别接种10μg 重组 HepB 和5μg 重组 HepB 疫苗,并在免后7个月、12个月和18个月分别采集静脉血进行免疫应答评价。结果免疫后7个月、12个月和18个月的抗-HBs 的几何平均浓度,5μg HepB -SCY 分别为(714.79±3.50)、(259.89±3.87)和(78.38±4.04)mIU /mL,10μg HepB -HPY 分别为(2420.76±3.51)、(703.55±3.46)和(171.32±3.76)mIU /mL,10μg 组的几何平均浓度均高于5μg 组(P 均<0.01)。免后7、12、18月的抗-HBs 低/无应答(<100 mIU /mL)率,5μg 组分别为6.39%、23.33%和55.42%,10μg 组分别为2.17%、5.17%和31.95%,5μg 组均高于10μg 组(P 均<0.01)。结论不同时期10μg 重组 HepB 的免疫应答均优于5μg 重组 HepB。
目的:瞭解新生兒接種不同類型乙型肝炎(乙肝)疫苗(HepB)後不同時期的免疫應答狀況。方法選擇餘姚市和寧海縣乙肝病毒錶麵抗原(HBsAg)陰性母親2375人在2009年7月1日—12月31日分娩的新生兒作為研究對象,按照0、1、6箇月免疫程序分彆接種10μg 重組 HepB 和5μg 重組 HepB 疫苗,併在免後7箇月、12箇月和18箇月分彆採集靜脈血進行免疫應答評價。結果免疫後7箇月、12箇月和18箇月的抗-HBs 的幾何平均濃度,5μg HepB -SCY 分彆為(714.79±3.50)、(259.89±3.87)和(78.38±4.04)mIU /mL,10μg HepB -HPY 分彆為(2420.76±3.51)、(703.55±3.46)和(171.32±3.76)mIU /mL,10μg 組的幾何平均濃度均高于5μg 組(P 均<0.01)。免後7、12、18月的抗-HBs 低/無應答(<100 mIU /mL)率,5μg 組分彆為6.39%、23.33%和55.42%,10μg 組分彆為2.17%、5.17%和31.95%,5μg 組均高于10μg 組(P 均<0.01)。結論不同時期10μg 重組 HepB 的免疫應答均優于5μg 重組 HepB。
목적:료해신생인접충불동류형을형간염(을간)역묘(HepB)후불동시기적면역응답상황。방법선택여요시화저해현을간병독표면항원(HBsAg)음성모친2375인재2009년7월1일—12월31일분면적신생인작위연구대상,안조0、1、6개월면역정서분별접충10μg 중조 HepB 화5μg 중조 HepB 역묘,병재면후7개월、12개월화18개월분별채집정맥혈진행면역응답평개。결과면역후7개월、12개월화18개월적항-HBs 적궤하평균농도,5μg HepB -SCY 분별위(714.79±3.50)、(259.89±3.87)화(78.38±4.04)mIU /mL,10μg HepB -HPY 분별위(2420.76±3.51)、(703.55±3.46)화(171.32±3.76)mIU /mL,10μg 조적궤하평균농도균고우5μg 조(P 균<0.01)。면후7、12、18월적항-HBs 저/무응답(<100 mIU /mL)솔,5μg 조분별위6.39%、23.33%화55.42%,10μg 조분별위2.17%、5.17%화31.95%,5μg 조균고우10μg 조(P 균<0.01)。결론불동시기10μg 중조 HepB 적면역응답균우우5μg 중조 HepB。
Objective To know the immunologic response at different periods with different hepatitis B vaccine(HepB)in infants.Methods From July 1 to December 31 in 2009,the local infants born from hepatitis B virus(HBV)surface antigen (HBsAg)negative mother in Ninghai were selected and received a 0.5 ml of 5 -μg HepB made by recombinant deoxyribonucleic acid (DNA)techniques in saccharomyces cerevisiae yeast (HepB -SCY)and those in Yuyao were selected and received a 0.5 ml of 10 -μg HepB made by recombinant DNA techniques in hansenula polymorpha yeast (HepB -HPY)with a 0 -1 -6 month schedule.The specimens of blood were collected at 7 months,12 months and 18 months after vaccination for testing antibody.Results At 7 months,12 months and 18 months after vaccination,the geometric mean concentration (GMC)of Anti -HBs in HepB -SCY group were 714.79 ±3.50 mIU /mL,259.89 ± 3.87 mIU /mL and 78.38 ±4.04 mIU /mL,respectively.While in HepB -HPY group were 2 420.76 ±3.51 mIU /mL, 703.55 ±3.46 mIU /mL and 171.32 ±3.76 mIU /mL,respectively.There was statistical significant difference of GMC between HepB -SCY group and HepB -HPY group(P <0.01).The percent of antibody <100 mIU /mL in HepB -SCY group were 6.39%,23.33% and 55.42%,and in HepB -HPY group,were 2.17%,5.17% and 31.95%,respectively. The difference between HepB -SCY group and HepB -HPY group had significantly statistical significance (P <0.01 ). Conclusion The immunologic response at different periods of HepB -HPY was better than that of HepB -SCY.